1. Scrip
  2. >>Business

Finance Watch: Many Mega-Rounds, Some Smaller VC Deals, But Few In The Middle

$100m-Plus Financings Leave Little For Mid-Sized Rounds

 
• By Mandy Jackson

Private Company Edition: June’s eight $100m-plus venture capital rounds already outpace the seven each raised in March, April and May, including €255m ($274.2m) for ITM and $200m for Upstream, but while there were five $25m or less VC financings during the past week, mid-sized deals were lacking.

Finance Watch Private Company
• Source: Shutterstock

The volume of $100m-plus venture capital mega-rounds continues to build throughout 2023 after a slow start, but a wider look at the biopharmaceutical VC landscape illustrates the valley of death that has emerged as venture capital investors exercise discretion.

There were eight mega-rounds announced between 5 and 12 June, including £96m ($120m) in initial funding for Beacon Therapeutics Holdings...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Financing

More from Business